Top Markets
Coin of the day
Heyu Biological Technology Corporation Heyu Biological Technology Corporation

Heyu Biological Technology Corporation

HYBT
Rank in Stocks #27962
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on... Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease. The company, incorporated in 1987 and headquartered in Xiamen, People's Republic of China, was formerly known as Pacific WebWorks, Inc., before adopting its current name, Heyu Biological Technology Corporation, in June 2018.
Share Price
$0.2853
Last synced: 2023-12-15
Market Cap
$29.46M
Change (1 day)
4.70%
Change (1 year)
0.00%
Country
CN
Trade Heyu Biological Technology Corporation (HYBT)

Category

P/B ratio for Heyu Biological Technology Corporation (HYBT)
P/B ratio as of 2026 TTM: 0
According to Heyu Biological Technology Corporation latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Heyu Biological Technology Corporation from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US